Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERASTUN: Low-Dose Aspirin for Prevention of Pre-eclampsia and SGA
NCT01729468Phase 4Completed
- Sponsor
- University Hospital Tours
- Start
- Jun 2012
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of aspirin in preeclampsia, intrauterine growth restriction (IUGR), sponsored by University Hospital Tours. Started Jun 2012; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsiaintrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NCT01729468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01729468.